Article Data

  • Views 2779
  • Dowloads 250

Case Reports

Open Access

Early Initiation of Veno-venous Extracorporeal Membrane Oxygenation in the Emergency Room as A Salvage Treatment for Patients with Coronavirus Disease 2019 with Severe Acute Respiratory Distress Syndrome

  • Kenta Aida1
  • Kazunari Azuma1
  • Kentaro Morinaga1
  • Yuki Nishiyama1
  • Kazuma Kimura1
  • Jun Oda1

1Department of Emergency and Critical Care Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan

DOI: 10.22514/sv.2020.16.0102 Vol.17,Issue 2,March 2021 pp.219-222

Published: 08 March 2021

*Corresponding Author(s): Kenta Aida E-mail:


Background: Since veno-venous extracorporeal membrane oxygenation (VV-ECMO) is highly invasive and may be used over a long period of time, its introduction is usually carefully considered and planned. Here, we report the case of a life-saving procedure by introducing VV-ECMO in the emergency room.

Case presentation: A 56 year-old man had fatigue for 3 days along with rapidly worsening dyspnea. On arrival at the emergency room, he presented with severe hypoxemia. Tracheal intubation and mechanical ventilation were immediately initiated; however, hypoxemia persisted. Therefore, VV-ECMO was introduced in the emergency room. The patient’s respiratory condition gradually improved, and VV-ECMO was terminated on hospital day 6.

Conclusion: The early introduction of VV-ECMO in the emergency room was effective against acute respiratory distress syndrome caused by coronavirus disease 2019. Further studies should be performed to confirm the efficacy of early VV-ECMO introduction.


Extracorporeal membrane oxygenation, COVID-19, Severe acute respiratory syndrome coronavirus 2, Critical care

Cite and Share

Kenta Aida,Kazunari Azuma,Kentaro Morinaga,Yuki Nishiyama,Kazuma Kimura,Jun Oda. Early Initiation of Veno-venous Extracorporeal Membrane Oxygenation in the Emergency Room as A Salvage Treatment for Patients with Coronavirus Disease 2019 with Severe Acute Respiratory Distress Syndrome. Signa Vitae. 2021. 17(2);219-222.


[1] Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240:595-605.

[2] Ramanathan K, Antognini D, Combes A, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8:518-526.

[3] Zeng Y, Cai Z, Xianyu Y, et al. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Crit Care. 2020;24:148.

[4] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.

[5] Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934-943.

[6] The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corti-costeroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020.

[7] The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19- preliminary report. N Engl J Med. 2020. doi:10.1056/NEJMoa2021436.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time